Metal-induced diffuse lung disease

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 6, 2008, Pages 662-669

  Fontenot, Andrew P ^a   Amicosante, Massimo ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Fibrosis; Genetic susceptibility; Granuloma; Lung; Metals; T cells

Indexed keywords

ALUMINUM; BERYLLIUM; CADMIUM; COBALT; COPPER; HLA DP ANTIGEN; NICKEL;

BERYLLIOSIS; CD4+ T LYMPHOCYTE; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; IMMUNOPATHOGENESIS; LUNG FIBROSIS; LUNG LAVAGE; NICKEL HYPERSENSITIVITY; PRIORITY JOURNAL; REVIEW;

ALLOYS; BERYLLIOSIS; BERYLLIUM; CHRONIC DISEASE; COBALT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHALATION EXPOSURE; LUNG DISEASES, INTERSTITIAL; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; TUNGSTEN;

EID: 61849093117     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1101276     Document Type: Review

References (69)

1. Newman LS, Maier LA. Beryllium disease. In: Schwarz MI, King TE Jr., eds. Interstitial Lung Disease. 3rd ed. Hamilton: BC Decker; 2003:435-451
2. Kelleher PC, Martyny JW, Mroz MM, et al. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med 2001;43:238-249
3. 3. Am J Ind Med 1996;30:16-25
4. Kreiss K, Newman LS, Mroz M, Campbell PA. Screening blood test identifies subclinical beryllium disease. J Occup Med 1989;31:603-608
5. Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations. J Occup Med 1993;35:267-274
6. Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 1993;148:985-991
7. Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 2001;74:167-176
8. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 2004;171:54-60
9. Fontenot AP, Newman LS, Kotzin BL. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Clin Immunol 2001;100:4-14
10. Fontenot AP, Kotzin BL. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 2003;62:449-458
11. NewmanLS,KreissK,KingTEJr,SeayS,CampbellPA. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis 1989;139:1479-1486
12. Williams WJ, Kelland D. New aid for diagnosing chronic beryllium disease (CBD): laser ion mass analysis (LIMA). J Clin Pathol 1986;39:900-901
13. Williams WJ, Wallach ER. Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis, and other granulomatous diseases. Sarcoidosis 1989;6:111-117
14. Newman LS, Lloyd J, Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect 1996;104:(Suppl 5):937-943
15. Rossman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Intern Med 1988;108:687-693
16. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989;320:1103-1109
17. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990;171:1123-1140
18. Fontenot AP, Falta MT, Freed BM, Newman LS, Kotzin BL. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol 1999;163:1019-1026
19. Fontenot AP, Kotzin BL, Comment CE, Newman LS. Expansions of T-cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease. Am J Respir Cell Mol Biol 1998;18:581-589
20. Fontenot AP, Maier LA, Canavera SJ, et al. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol 2002;168:3627-3634
21. + T cells in patients with chronic beryllium disease. J Clin Invest 2002;110:1473-1482
22. + T cells in patients with beryllium-induced disease. J Allergy Clin Immunol 2005;115:1036-1042
23. + T cells in blood determines proliferative response. J Clin Invest 2005;115:2886-2893
24. Tinkle SS, Kittle LA, Schumacher BA, Newman LS. Beryllium induces IL-2 and IFN-γ in berylliosis. J Immunol 1997;158:518-526
25. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-244
26. Richeldi L, Kreiss K, Mroz MM, Zhen B, Tartoni P, Saltini C. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 1997;32:337-340
27. Wang Z, White PS, Petrovic M, et al. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and-DPA1 alleles. J Immunol 1999;163:1647-1653
28. Saltini C, Richeldi L, Losi M, et al. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 2001;18:677-684
29. Wang Z, Farris GM, Newman LS, et al. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 2001;165:27-38
30. Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 2002;165:788-794
31. Maier LA, McGrath DS, Sato H, et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 2003;171:6910-6918
32. McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 2004;46:95-103
33. Amicosante M, Berretta F, Rossman M, et al. Identification of HLA-DRPheß47 as the susceptibility marker of hyper-sensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69. Respir Res 2005;6:94
34. + T cells underlies disease susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci USA 2000;97:12717-12722
35. Lombardi G, Germain C, Uren J, et al. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol 2001;166:3549-3555
36. Bill JR, Mack DG, Falta MT, et al. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol 2005;175:7029-7037
37. Fontenot AP, Keizer TS, McCleskey M, et al. Recombi-nant HLA-DP2 binds beryllium and tolerizes beryllium-specificpathogenicCD4+ T cells. J Immunol 2006;177:3874-3883
38. De Wall SL, Painter C, Stone JD, et al. Noble metals strip peptides from class II MHC proteins. Nat Chem Biol 2006; 2:197-201
39. Penzotti JE, Nepom GT, Lybrand TP. Use of T cell receptor/HLA- DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum 1997;40:1316-1326
40. Amicosante M, Fontenot AP. T cell recognition in chronic beryllium disease. Clin Immunol 2006;121:134-143
41. Kelleher P, Pacheco K, Newman LS. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 2000;108(Suppl 4):685S-696S
42. CowieR,MurrayJ,BecklakeM.Pneumoconioses. In: Mason R, Murray J, Broaddus V, Nadel J, eds. Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia: Elsevier/Saunders; 2005:1748-1782
43. Meyer-Bisch C, Pham QT, Mur JM, et al. Respiratory hazards in hard metal workers: a cross sectional study. Br J Ind Med 1989;46:302-309
44. Sprince NL, Chamberlin RI, Hales CA, Weber AL, Kazemi H. Respiratory disease in tungsten carbide production workers. Chest 1984;86:549-557
45. Sprince NL, Oliver LC, Eisen EA, Greene RE, Chamberlin RI. Cobalt exposure and lung disease in tungsten carbide production. A cross-sectional study of current workers. Am Rev Respir Dis 1988;138:1220-1226
46. Zou S, Zou T, Ma F. An epidemiologic study on pulmonary fibrosis caused by hard alloy dust. Zhonghua Yu Fang Yi Xue Za Zhi 1995;29:70-72
47. Posgay M, Nemeth L, Mester A. Radiological aspects of hard metal disease. Rofo 1993;159:439-443
48. Frost AE, Keller CA, Brown RW, et al. Giant cell interstitial pneumonitis: disease recurrence in the transplanted lung. Am Rev Respir Dis 1993;148:1401-1404
49. Forni A. Bronchoalveolar lavage in the diagnosis of hard metal disease. Sci Total Environ 1994;150:69-76
50. Al-Tawil NG, Marcusson JA, Moller E. In vitro testing for cobalt sensitivity: an aid to diagnosis. Acta Derm Venereol 1984;64:203-208
51. Kusaka Y, Nakano Y, Shirakawa T, Morimoto K. Lymphocyte transformation with cobalt in hard metal asthma. Ind Health 1989;27:155-163
52. PotolicchioI,MosconiG,ForniA,NemeryB,SeghizziP, Sorrentino R. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain. Eur J Immunol 1997;27:2741-2743
53. Potolicchio I, Festucci A, Hausler P, Sorrentino R. HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. Eur J Immunol 1999;29:2140-2147
54. Voisin C, Fisekci F, Buclez B, et al. Mineralogical analysis of the respiratory tract in aluminum oxide-exposed workers. Eur Respir J 1996;9:1874-1879
55. Lindenschmidt RC, Driscoll KE, Perkins MA, Higgins JM, Maurer JK, Belfiore KA. The comparison of a fibrogenic and two nonfibrogenic dusts by bronchoalveolar lavage. Toxicol Appl Pharmacol 1990;102:268-281
56. Armstrong CW, Moore LW Jr, Hackler RL, Miller GB Jr, Stroube RB. An outbreak of metal fume fever: diagnostic use of urinary copper and zinc determinations. J Occup Med 1983;25:886-888
57. Cohen SR. A review of the health hazards from copper exposure. J Occup Med 1974;16:621-624
58. Ostiguy G, Vaillancourt C, Begin R. Respiratory health of workers exposed to metal dusts and foundry fumes in a copper refinery. Occup Environ Med 1995;52:204-210
59. Pimentel JC, Marques F. ''Vineyard sprayer's lung'': a new occupational disease. Thorax 1969;24:678-688
60. Villar TG. Vineyard sprayer's lung: clinical aspects. Am Rev Respir Dis 1974;110:545-555
61. Townshend RH. Acute cadmium pneumonitis: a 17-year follow-up. Br J Ind Med 1982;39:411-412
62. Budinger L, Hertl M. Immunologic mechanisms in hyper-sensitivity reactions to metal ions: an overview. Allergy 2000;55:108-115
63. Moulon C, Vollmer J, Weltzien HU. Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol 1995;25:3308-3315
64. Emtestam L, Zetterquist H, Olerup O. HLA-DR,-DQ and-DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 1993;100:271-274
65. Sinigaglia F, Scheidegger D, Garotta G, Scheffer R, Pletscher M, Lanzavecchia A. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol 1985;135:3929-3932
66. Vollmer J, Weltzien HU, Dormoy A, Pistoor F, Moulon C. Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells. J Invest Dermatol 1999;113:175-181
67. Sinigaglia F. The molecular basis of metal recognition by T cells. J Invest Dermatol 1994;102:398-401
68. Romagnoli P, Labhardt AM, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991;10:1303-1306
69. Lu L, Vollmer J, Moulon C, Weltzien HU, Marrack P, Kappler J. Components of the ligand for a Ni+ + reactive human T cell clone. J Exp Med 2003;197:567-574